Cell Medica's Convertible Note Round

Cell Medica raised a round of funding on September 16, 2011. Investors include Wellcome Trust.

Cell Medica develops, manufactures and markets cellular immunotherapy products for the treatment of cancer and infections. The Company employs technologies to develop cell-based therapies with the pot…

Articles about Cell Medica's Convertible Note Round: